Literature DB >> 16921072

Thrombotic thrombocytopenic purpura mimicking acute ischemic stroke.

E Aksay1, S Kiyan, M Ersel, O Hudaverdi.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is an autoimmune disorder characterised by thrombocytopenia, haemolytic anemia, fluctuating neurological deficits, fever, and renal impairment. This case report is about a young man who presented with acute onset right sided paralysis, dysarthria, and central facial paralysis, suggestive of cerebrovascular accident, but eventually diagnosed as TTP. In addition, the clinical presentation of TTP is discussed and some teaching points for the emergency physicians are emphasised.

Entities:  

Mesh:

Year:  2006        PMID: 16921072      PMCID: PMC2564239          DOI: 10.1136/emj.2006.036327

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  4 in total

1.  Thrombotic thrombocytopenic purpura in southern Turkey: a single-center experience of 29 cases.

Authors:  E Gurkan; F Baslamisli; B Guvenc; N B Kilic; C Unsal; E Karakoc
Journal:  Clin Lab Haematol       Date:  2005-04

Review 2.  Recent advances in thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler; Joel L Moake; Toshiyuki Miyata; James N George
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

3.  von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.

Authors:  Flora Peyvandi; Silvia Ferrari; Silvia Lavoretano; Maria Teresa Canciani; Pier Mannuccio Mannucci
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

4.  ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

Authors:  Sara K Vesely; James N George; Bernhard Lämmle; Jan-Dirk Studt; Lorenzo Alberio; Mayez A El-Harake; Gary E Raskob
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

  4 in total
  4 in total

1.  Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.

Authors:  Jingrui Sui; Wenjing Cao; Konstantine Halkidis; Mohammad S Abdelgawwad; Nicole K Kocher; Bryan Guillory; Lance A Williams; Radhika Gangaraju; Marisa B Marques; X Long Zheng
Journal:  Blood Adv       Date:  2019-12-23

2.  Stroke due to typical thrombotic thrombocytopenic purpura treated successfully with intravenous thrombolysis and therapeutic plasma exchange.

Authors:  Matteo Boattini; Gaetano Procaccianti
Journal:  BMJ Case Rep       Date:  2013-01-28

3.  Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura.

Authors:  Ruinan Lu; Jingrui Sui; X Long Zheng
Journal:  Blood Adv       Date:  2020-11-10

4.  Thrombotic thrombocytopenic purpura with concomitant small- and large-vessel thrombosis, atypical posterior reversible encephalopathy syndrome and cerebral microbleeds.

Authors:  Wong Li Yu; Thomas Leung; Yannie Soo; Jessamyn Lee; Ka Sing Wong
Journal:  Oxf Med Case Reports       Date:  2015-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.